Édition française
ACS
Slides and resources
Antiplatelet therapies
Antiplatelet Therapy During PCI
Antiplatelet trials in 2008
The FellowShip Series: Late stent thrombosis
Stent thrombosis and antiplatelet therapy
Antithrombotic therapy: A year in review
More...
High-risk ACS
Update on STEMI
Optimizing outcomes
Steering Committee Members
2007 ACC/AHA UA/NSTEMI GUIDELINES
Horizons AMI
More...
Other ACS programs
Antiplatelet therapy for atherothrombotic disease
Acute STEMI: Overcoming Peri-Procedural Challenges in Patients Undergoing PCI
Optimal pharmacological management of STEMI
Optimizing patient outcomes in CAD
More...
HeartWire
Generic clopidogrel in Europe
ACUITY: Bivalirudin switching data
ACS guideline discrepancies
GI events and clopidogrel
Intracoronary spectroscopy catheter approved
More...
Cardiometabolic risk
Resource center
Abdominal obesity
Cardiometabolic Risk in the Spotlight
Taming abdominal obesity
Abdominal obesity: The perfect storm of CVD and diabetes
Prevention and lifestyle interventions to minimize CV risk
More...
Dysglycemia
Keys to prevention in diabetes and CV risk
Test your knowledge on risk assessment and intervention for patients with dysglycemia
Charting the course of CV risk in diabetes
Running the race against CV risk in diabetes
More...
HeartWire
Carotid bruits and CVD
Preventing diabetes in hypertensives
Triglycerides and CHD patients
BP-related disease neglected
Thiazolidinediones and fractures
More...
Clinical cardiology
Slides and resources
Difficult cases in coronary interventions
Atherothrombosis
US and European ACS guidelines
Antiplatelet therapy for atherothrombotic disease
Adjunctive pharmacology in PCI
Risk/Benefit or Benefit/Risk?
Antiplatelet Therapy Across the Cardiovascular Risk Spectrum
More...
HeartWire
GI events and clopidogrel
WAFACS: No benefit to homocysteine lowering
Depression and HF
Palliative care in heart failure and cancer
Thiazolidinediones and fractures
More...
Dyslipidemia
Low HDL-C: Survey
Slides and resources
Mixed dyslipidemia
Attenuating risk... treatment beyond LDL
Steering Committee Members
More...
HeartWire
Statins associated with increased progression of AMD, but caution is urged
Intensive atorvastatin
Niacin/laropiprant not approvable
ACHIEVE enrollment on hold
More...
Electrophysiology
Cardiac rhythm management
Remote monitoring: Creating a clinical consensus
Advances in remote monitoring
More...
HeartWire
Largest study on ICDs in kids
Denervation for CPVT
Risks of early repolarization
Digitek digoxin tablets recalled
Osteoporosis drug promotes atrial fib
More...
Heart failure
HeartWire
Depression and HF
Palliative care in heart failure and cancer
Remote monitoring helps HF patients not tied to home
Digitek digoxin tablets recalled
Precipitating factors affect CHF outcomes
More...
Hypertension
HeartWire
Preventing diabetes in hypertensives
BP-related disease neglected
Mice lacking angiotensin weigh less
More...
Interventional cardiology
Slides and resources
Drug-eluting stents
Economics of DES vs BMS
The disappearing stent: Bioabsorbable stents
The FellowShip Series: Late stent thrombosis
SCAI-ACCi2 2008: What's hot in interventional cardiology?
Challenging cases: Lower limb intervention
More...
HeartWire
Generic clopidogrel in Europe
ACUITY: Bivalirudin switching data
ACS guideline discrepancies
GI events and clopidogrel
Disclosure inconsistent across stent research
More...
Prevention
CV Risks - Survey #3
CV Risks - Survey #2
Slides and resources
CV Risks - Survey
Cardiovascular risks
Stories of 2007-the year in review
Variable conclusions of meta-analyses of RAS inhibition. What's a clinician to believe?
CKD and CVD: Examining strategies for target organ protection and CV risk reduction
Will new trials provide definitive answers?
Life saving drugs in life threatening situations
More...
HeartWire
Carotid bruits and CVD
Largest study on ICDs in kids
WAFACS: No benefit to homocysteine lowering
Inflammatory markers predict CHF
Never too late to stop
More...
HeartWire
News for the CV healthcare professional by theheart.org journalists
Generic clopidogrel in Europe
ACUITY: Bivalirudin switching data
Carotid bruits and CVD
ACS guideline discrepancies
FDA expands "extracellular matrix" biomaterial indications
Natale heads up new arrhythmia institute in Austin
Largest study on ICDs in kids
Hormone therapy linked to stroke risk regardless of timing of initiation
Denervation for CPVT
Risks of early repolarization
More...
Editorial series
A series of discussions among editorial leaders, developed by theheart.org
HeartBeat
Nissen. Califf. Rosiglitazone.
More...
The Cardiology Show
Surrogate end points on trial
AHA 2007
From disease treatment to health promotion
More...
Cardiology panels
From evidence to practice
The lowdown on HORIZONS
DES debate continues
Back to the ABCs for CHF?
Women and ACS
More...
HeartWire clips
On moving to industry: An interview with Dr Terry Ferguson
Face-to-face interviews
The Braunwald interview: TRITON-TIMI 38
DES showdown: Serruys vs Virmani
The Braunwald interview
More...
The EP show
Recall Reality
More...
Thumbs up, thumbs down
Controversies: ENHANCE and ACCORD
TRITON-TIMI 38 and ILLUMINATE
More...
CME programs
Accredited educational programs, supported by industry, developed by theheart.org
Acute coronary syndromes
Antiplatelet Therapy During PCI
Antiplatelet trials in 2008
Update on STEMI
Stent thrombosis and antiplatelet therapy
Optimizing outcomes
More...
Cardiometabolic risk
Cardiovascular disease: call to action for the cardiologist
Cardiometabolic Risk in the Spotlight
Taming abdominal obesity
Abdominal obesity: The perfect storm of CVD and diabetes
More...
Clinical cardiology
US and European ACS guidelines
Adjunctive pharmacology in PCI
Risk/Benefit or Benefit/Risk?
Current and emerging therapies in the management of VTE
More...
Dyslipidemia
Measuring plaque regression by statins
Attenuating risk... treatment beyond LDL
Statins in heart failure: What's new? - A Canadian perspective
More...
Electrophysiology
Improving outcomes in AF
More...
Heart Failure
Hyponatremia: Clinical challenges and unmet needs
Renal dysfunction in ADHF: Examining new strategies
More...
Hypertension
RAPiHD and more: Combination therapy in severe hypertension
MAU: marker of renal compromise AND heart disease
Optimizing Synergistic Effects in Antihypertensive Therapy
CV Protection: Beyond hypertension
A SMARTer approach to renal disease
More...
Interventional cardiology
Economics of DES vs BMS
The disappearing stent: Bioabsorbable stents
Slides and resources
The FellowShip Series: Late stent thrombosis
Decision 2008: The art and science of DES
More...
Prevention
Stories of 2007-the year in review
Variable conclusions of meta-analyses of RAS inhibition. What's a clinician to believe?
CV Risks - Survey #3
Statins and the vasculature
CKD and CVD: Examining strategies for target organ protection and CV risk reduction
More...
Academic series
Duke Clinical Medicine Series
Sponsored education
Promotional educational programs developed under the direction of our sponsors
Branded infosites
Actos
Lovaza
Central Blood Pressure Resource Center
Condition infosites
Atrial Fibrillation infosite
Promotional educational programs
Endothelin receptor antagonists
Tirofiban in STEMI
CREATE annual meeting
CORONA study results
RecordAF Registry: An international, observational, prospective survey assessing the control of Atrial Fibrillation
Press Center
Forum
In-depth discussions, moderated by Dr Melissa Walton-Shirley
oh canada
Afib Ablation Complications
Heparin contamination was deliberate act to cut costs?
Managed-care data suggest high frequency of GI events from clopidogrel
Vascular benefits of stopping smoking are rapid
More...
The Fellows' corner
Cardiology panels
From evidence to practice: Narrowing the gap
Dr Keith Fox
talks to
Drs Gregg Stone
and
Robert Harrington
about why it takes so long for new evidence-based therapies to be adopted in clinical practice, the importance of national registries, and what can be done to make treatment guidelines more useful.
Genetic beta-blockade
What are the implications of an exciting discovery of intrinsic genetic beta-blockade common to 40% of people of African ancestry?
Dr Eric Topol
invites you to share your opinions.
Click here to view the video blog and join the discussion.
HeartWire clips
On moving to industry: Interview with Dr Terry Ferguson
In conversation with
heart
wire
news and features editor
Larry Husten
,
Dr Terry Ferguson
muses on changes to daily life, decision making processes, and patient care from a different perspective resulting from his new position in industry.
The Cardiology Show
Surrogate end points on trial: ENHANCE and other controversies
Part 2 is now live!
Nine of the world's top cardiologists gathered in Chicago to take on the issues raised by data released at the
American College of Cardiology Scientific Sessions
.
Dr Valentin Fuster
moderates this frank and sometimes heated discussion on the results of
ENHANCE
,
STRADIVARIUS
,
ONTARGET
, and
PERISCOPE
, and the questions they raise about the responsibility of industry and the relevance of surrogate end points.
Forum
Smoking ban?
Read about our forum moderator's heroic and sometimes comic efforts to get a smoking ban passed by her city council in tobacco country.
Thumbs up, thumbs down
Controversies: ENHANCE and ACCORD
Clinical trials are under attack and in the headlines. What is the proper role of the investigators? What are the responsibilities of industry? Join
Drs Eric J Topol
and
Robert M Califf
in a discussion of the many issues surrounding
ENHANCE
and
ACCORD
.
Question
Do you think the ACC and SCAI should continue to combine their annual meetings in future years?
(See:Arranged marriage: Funding and "cultural differences" may dictate whether SCAI-ACC/i2 stay hitched)
No
Yes
Vote
Electrophysiology
Boston Scientific announces ICD, CRT-D approvals
To view the full text of this article, you must be logged in as a registered member.
Members
Login Now
Not a member
Free registration
Username
Password
Forgot your password?
Remember me
Start by choosing your professional category:
Cliquer ici pour l'édition française
Healthcare professional
Medical industry professional
Media representative
Medical librarian